HIMSHealthcareMid-Cap

Hims & Hers Health, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Hims & Hers Health, Inc. (HIMS), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are HIMS insiders buying or selling?

Hims & Hers Health, Inc. insiders reported 9 open-market buys ($7.2M) and 315 sells ($386.8M) across 324 Form 4 filings — a net selling position of $379.6M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 20, 2026)

Total Form 4 filings
324
SEC EDGAR
Insider filers
20
Insider buys (9)
$7.2M
Insider sells (315)
$386.8M

Insider sentiment

Net selling

Net insider flow of $379.6M in net selling. 1 insider buy in the last 90 days.

Recent HIMS insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 20, 2026Oluyemi OkupeChief Financial OfficerSale7.2K$31.99$229.2K
Jul 7, 2026Oluyemi OkupeChief Financial OfficerSale7.2K$36.49$261.4K
Jun 23, 2026Patrick Harrison CarrollChief Medical OfficerSale23.7K$35.00$830.4K
Jun 23, 2026Oluyemi OkupeChief Financial OfficerSale18.2K$34.03$619.2K
Jun 17, 2026Michael ChiChief Operating OfficerSale14.0K$31.50$441.9K
Jun 17, 2026Irene BecklundPAOSale12.1K$30.72$370.5K
Jun 17, 2026Mohamed ElshenawyCTOSale30.0K$31.50$946.3K
May 26, 2026David B WellsDirectorPurchase48.4K$24.24$1.2M
May 19, 2026Oluyemi OkupeChief Financial OfficerSale8.0K$23.64$187.9K
Apr 22, 2026Soleil BoughtonChief Legal OfficerSale9.5K$30.00$283.9K
Apr 22, 2026Oluyemi OkupeChief Financial OfficerSale19.6K$29.96$588.6K
Apr 20, 2026Oluyemi OkupeChief Financial OfficerSale54.9K$26.53$1.5M
Apr 7, 2026Oluyemi OkupeChief Financial OfficerSale4.0K$19.98$79.4K
Mar 24, 2026Oluyemi OkupeChief Financial OfficerSale9.2K$23.77$219.1K
Mar 18, 2026Irene BecklundPAOSale5.5K$24.69$136.5K
Mar 18, 2026Soleil BoughtonChief Legal OfficerSale4.8K$24.69$118.8K
Mar 18, 2026Michael ChiChief Operating OfficerSale97.3K$24.69$2.4M
Mar 2, 2026Soleil BoughtonChief Legal OfficerSale4.7K$15.21$70.7K
Feb 4, 2026Oluyemi OkupeChief Financial OfficerSale5.3K$26.44$139.1K
Jan 21, 2026Oluyemi OkupeChief Financial OfficerSale9.1K$30.34$275.1K
Jan 7, 2026Oluyemi OkupeChief Financial OfficerSale9.1K$33.79$306.5K
Dec 23, 2025Oluyemi OkupeChief Financial OfficerSale23.1K$35.72$824.7K
Dec 18, 2025Michael ChiChief Operating OfficerSale13.8K$36.71$504.8K
Dec 18, 2025Deborah M. AutorChief Policy OfficerSale7.1K$36.71$259.0K
Dec 18, 2025Patrick Harrison CarrollChief Medical OfficerSale10.0K$36.71$367.9K

Showing the 25 most recent of 324 Form 4 filings for Hims & Hers Health, Inc..

Most active HIMS insiders

  • Soleil Boughton67 filings
  • Oluyemi Okupe53 filings
  • Andrew Dudum48 filings
  • Michael Chi43 filings
  • Irene Becklund36 filings

Ask anything about HIMS insider activity

Use Trabud's AI agent to query Hims & Hers Health, Inc.'s Form 4 history in plain English — "Show me HIMS CEO purchases this year" or compare it against any other ticker.

Open the AI agent

HIMS insider trading FAQ

Are Hims & Hers Health, Inc. insiders buying or selling?

Across 324 SEC Form 4 filings, Hims & Hers Health, Inc. (HIMS) insiders reported 9 open-market purchases totaling $7.2M and 315 sales totaling $386.8M. That is a net selling position of $379.6M.

How many insiders trade HIMS stock?

20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Hims & Hers Health, Inc.. The most recent filing was accepted on Jul 20, 2026.

Where does Trabud get HIMS insider trading data?

All HIMS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content